Advances in the management of idiopathic pulmonary fibrosis.
Idiopathic pulmonary fibrosis (IPF) is a common form of interstitial lung disease and usually results in progressive respiratory insufficiency and death. Steady progress has been made in understanding the pathogenesis of IPF and multiple clinical trials are ongoing, but effective therapy remains elusive.
Ryu
Jay H
JH
Division of Pulmonary and Critical Care Medicine, Mayo Clinic College of Medicine, 200 1st Street SW, Rochester, MN 55905, USA.
Daniels
Craig E
CE